Skip to content

Study · Measured the body's own peptide · 1985

3 results

The coexistence of oxytocin and corticotropin-releasing factor in the hypothalamus: an immunocytochemical study in the rat, sheep and hedgehog.

Papadopoulos GC, Karamanlidis AN, Michaloudi H, Dinopoulos A, Antonopoulos J, Parnavelas JG

Neuroscience letters1 Dec 1985Cited by 16 (Europe PMC)

PMID2418388 (opens in a new tab)DOI10.1016/0304-3940(85)90357-x (opens in a new tab)PepBankPUB-02418388
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelEx vivo tissueOther

    In the paraventricular nucleus of colchicine-treated rats, the body's own oxytocin and corticotropin-releasing factor immunoreactivities were both expressed by a number of cells.

    In plain wordsIn rat tissue sections, the body's own oxytocin and CRF immunoreactivities were both expressed by a number of paraventricular cells.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin and CRF immunoreactivities in paraventricular nucleus (rat)
    Study

    ratn: not reported in source

    Immunocytochemistry of hypothalamic paraventricular nucleus
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    although OXY and CRF immunoreactivities are both expressed by a number of cells in the rat and the sheep paraventricular nucleus
    1 context sentence
    Summary · context
    The unlabeled antibody enzyme method has been applied on adjacent sections in order to investigate coexistence of oxytocin (OXY) and corticotropin-releasing factor (CRF) within individual neurons of the hypothalamic paraventricular nucleus of the colchicine-treated rat, sheep and hedgehog.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

  2. 02LabEndogenous levelEx vivo tissueOther

    In the paraventricular nucleus of colchicine-treated sheep, the body's own oxytocin and corticotropin-releasing factor immunoreactivities were both expressed by a number of cells.

    In plain wordsIn sheep tissue sections, the body's own oxytocin and CRF immunoreactivities were both expressed by a number of paraventricular cells.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin and CRF immunoreactivities in paraventricular nucleus (sheep)
    Study

    sheepn: not reported in source

    Immunocytochemistry of hypothalamic paraventricular nucleus
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    although OXY and CRF immunoreactivities are both expressed by a number of cells in the rat and the sheep paraventricular nucleus
    1 context sentence
    Summary · context
    The unlabeled antibody enzyme method has been applied on adjacent sections in order to investigate coexistence of oxytocin (OXY) and corticotropin-releasing factor (CRF) within individual neurons of the hypothalamic paraventricular nucleus of the colchicine-treated rat, sheep and hedgehog.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

  3. 03LabEndogenous levelEx vivo tissueOther

    In the hedgehog paraventricular nucleus, oxytocin and corticotropin-releasing factor immunoreactivities were not both expressed by a number of cells, unlike in rats and sheep.

    In plain wordsIn hedgehog sections, the body's own oxytocin and CRF immunoreactivities were not both expressed by a number of cells, unlike in rats and sheep.

    Peptide
    Oxytocin
    Outcome
    Direction not reportedOxytocin and CRF immunoreactivities in hedgehog paraventricular nucleus
    Study

    hedgehogn: not reported in source

    Immunocytochemistry of hypothalamic paraventricular nucleus
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Our results show that, although OXY and CRF immunoreactivities are both expressed by a number of cells in the rat and the sheep paraventricular nucleus, this is not the case for the hedgehog.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.